Frederic Berst, Global Discovery Chemistry
Frederic Berst, Global Discovery Chemistry

Klaus Moosmayer, Ph.D.

Chief Ethics, Risk & Compliance Officer of Novartis since 2018

Klaus Moosmayer, Ph.D.

Chief Ethics, Risk & Compliance Officer of Novartis since 2018

Frederic Berst, Global Discovery Chemistry

Klaus Moosmayer joined Novartis in 2018 as Chief Ethics, Risk & Compliance Officer. In this role, he oversees several important functions that help Novartis deliver on its strategy to build trust with society.

Today, Klaus is transforming ethics, risk and compliance at Novartis in the same way the company is reimagining medicine – by pursuing innovation, using data and digital, and unleashing the creative power of employees to embed ethics into the core of the business.

Doing what’s right for patients and society is, and must always be, our priority. It’s a journey, and we remain humble in our understanding that this will take time. But we are well on our way.

Klaus led the launch of a new Code of Ethics in 2020, based on crowdsourced feedback from employees and on behavioral science. He introduced an integrated risk management system that helps senior management prioritize and manage key risks across the company, supported by a new policy and control framework. And he set up a new process to ensure human rights are further integrated into core business practices, especially third-party risk management.

Klaus brings a global reputation as a leader in the field of ethics and compliance. He was the first head of compliance from a company to be invited to address the General Assembly of the United Nations about the fight against corruption. He leads global integrity, compliance and anti-corruption bodies for business on behalf of the Organization for Economic Co-operation and Development (OECD) and the G20/B20.

As a believer in collaboration, Klaus co-founded and chaired a nonprofit association of compliance heads from major European companies, and is on the Advisory Panel of the Pharmaceutical Supply Chain Initiative to further drive compliance standards at an international level.

Klaus was previously chief compliance officer at Siemens AG, where he spent 18 years in roles of increasing seniority. He began his career as a lawyer in Germany, specializing in white-collar crime, business law and litigation.

Outside of work, Klaus enjoys spending time with his family, practicing sports, and driving his vintage car.

Nationality: German | Year of birth: 1968

Professional experience

  • Chief compliance officer, Siemens AG, Germany (2014–2018)
  • Chief counsel compliance, Siemens AG, Germany (2009–2013)
  • Compliance operating officer, Siemens AG, Germany (2007–2009)

Mandates

  • Board member, SwissHoldings, the Swiss federation representing the Swiss based multinational companies, Switzerland
  • Co-chair, B20 Integrity & Compliance Task Force under the G20 presidency of Italy (2021)
  • Vice chair, Business at OECD (BIAC) executive board, Paris
  • Member of the advisory panel, Pharmaceutical Supply Chain Initiative, US
  • Co-founder and board member, European Chief Compliance and Integrity Officers’ Forum
  • Chair of the Anti-Corruption Committee of the Business and Industry Advisory Committee (BIAC), Organization for Economic Co-operation and Development (OECD), Paris (2013–2020)
  • Co-chair, B20 Integrity & Compliance Task Force under the G20 presidency of Saudi Arabia (2020)
  • Co-chair, B20 Integrity & Compliance Task Force under the G20 presidency of Argentina (2018)
  • Chair, B20 Integrity & Compliance Task Force under the G20 presidency of Germany (2017)

Education

  • First and second state examination in law, Germany
  • Doctor of jurisprudence, University of Freiburg, Germany

Information is accurate as of Apr 7, 2021


Source URL: https://www.novartis.com/about/executive-committee/klaus-moosmayer

List of links present in page